Nu Skin Enterprises, Inc. (NYSE:NUS) Sees Significant Increase in Short Interest

Nu Skin Enterprises, Inc. (NYSE:NUS) was the recipient of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 1,644,200 shares, an increase of 8.6% from the May 15th total of 1,513,800 shares. Currently, 3.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 677,400 shares, the short-interest ratio is presently 2.4 days.

Several equities research analysts recently weighed in on NUS shares. Citigroup reduced their price target on shares of Cimarex Energy from $98.00 to $90.00 and set a “buy” rating on the stock in a research report on Thursday. Jefferies Financial Group lowered shares of Keppel REIT from a “buy” rating to a “hold” rating in a research note on Wednesday. Bank of America dropped their price objective on shares of Canopy Growth from $80.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday, June 19th. Zacks Investment Research lowered shares of Inflarx from a “buy” rating to a “hold” rating in a research note on Friday, May 3rd. Finally, ValuEngine raised shares of Valmont Industries from a “sell” rating to a “hold” rating in a research note on Friday, July 12th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $55.63.

NYSE:NUS traded up $1.65 during mid-day trading on Friday, reaching $40.99. The company’s stock had a trading volume of 1,083,718 shares, compared to its average volume of 817,718. Nu Skin Enterprises has a 1 year low of $35.03 and a 1 year high of $88.68. The business’s fifty day simple moving average is $47.56. The stock has a market capitalization of $2.27 billion, a price-to-earnings ratio of 11.64, a PEG ratio of 1.03 and a beta of 0.74. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.86 and a quick ratio of 1.10.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.06. The company had revenue of $623.60 million during the quarter, compared to analyst estimates of $615.98 million. Nu Skin Enterprises had a net margin of 4.82% and a return on equity of 26.81%. The firm’s revenue for the quarter was up 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.79 earnings per share. As a group, equities analysts forecast that Nu Skin Enterprises will post 3.27 earnings per share for the current year.

Institutional investors have recently made changes to their positions in the business. Mackay Shields LLC raised its holdings in Nu Skin Enterprises by 79.0% in the fourth quarter. Mackay Shields LLC now owns 79,714 shares of the company’s stock worth $4,889,000 after purchasing an additional 35,188 shares in the last quarter. Delek Group Ltd. acquired a new position in shares of Nu Skin Enterprises during the first quarter valued at about $17,859,000. Amalgamated Bank increased its holdings in shares of Nu Skin Enterprises by 14.8% during the fourth quarter. Amalgamated Bank now owns 11,484 shares of the company’s stock valued at $704,000 after acquiring an additional 1,483 shares in the last quarter. Squarepoint Ops LLC increased its holdings in shares of Nu Skin Enterprises by 55.4% during the fourth quarter. Squarepoint Ops LLC now owns 109,000 shares of the company’s stock valued at $6,685,000 after acquiring an additional 38,844 shares in the last quarter. Finally, BlackRock Inc. increased its holdings in shares of Nu Skin Enterprises by 3.4% during the fourth quarter. BlackRock Inc. now owns 6,273,298 shares of the company’s stock valued at $384,741,000 after acquiring an additional 205,481 shares in the last quarter. Institutional investors and hedge funds own 77.17% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Further Reading: What is a recession?

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.